|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,057 INR | -1.30% |
|
+1.72% | +23.80% |
| Apr. 29 | Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Pain Relief Medicines | MT |
| Apr. 25 | Glenmark Lifesciences' Net Profit Slides in Fiscal Q4 | MT |
This is to inform you that
Contact:
Glenmark House
B D Sawant Marg
Andheri (E)
T: 91 22 4018 9999
F: 91 22 4018 9988
CIN: L24299MH1977PLC019982
W: www.glenmarkpharma.com
Registered office
B/2,
E: complianceofficer@glenmarkpharma.co
(C) 2021 Electronic News Publishing, source
| 1st Jan change | Capi. | |
|---|---|---|
| +23.80% | 3.62B | |
| +19.27% | 43.75B | |
| +27.47% | 22.06B | |
| +15.11% | 14.46B | |
| +12.33% | 13.62B | |
| +38.36% | 11.61B | |
| -9.54% | 6.9B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +9.64% | 5.32B |
GLENMARK PHARMACEUTICALS LIMITED 
